View all newsletters
AbbVie has obtained orphan drug designation from the European Medicines Agency (EMA) and the US FDA for its anti-epidermal growth factor receptor monoclonal antibody drug conjugate,…
ByPfizer and Baxter have entered into a definitive agreement under which Pfizer will acquire Baxter’s portfolio of marketed vaccines…
BySwedish drugmaker Meda has agreed to acquire Italy-based Rottapharm Madaus for around €2.3bn as part of its strategy to…
ByBayer has announced the US Food and Drug Administration’s (FDA) approval of Eylea, an aflibercept solution for injection into…
BySpain-based Almirall and AstraZeneca have entered into an agreement, involving Almirall transfering the rights to its respiratory franchise to…
ByThe European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on…
ByBristol-Myers Squibb and Pfizer have announced the European Commission’s approval of Eliquis, an oral selective Factor Xa inhibitor, to…
ByClinical stage biopharmaceutical company Clementia Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA)…
ByThe European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the full marketing approval…
ByThank you for subscribing to Pharmaceutical Technology